Company Filing History:
1 out of 2 
1 out of 3 
1 out of 1 Years Active: 2017-2024
Title: Montserrat Trilla Castaño: Innovator in Cannabinoid Research
Introduction
Montserrat Trilla Castaño is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of cannabinoid research, holding a total of 3 patents. Her work focuses on the development of solid compositions and pharmaceutical formulations that utilize cannabinoids for therapeutic and cosmetic applications.
Latest Patents
One of her latest patents is titled "Solid compositions of cocrystals of cannabinoids." This invention relates to solid compositions that comprise cocrystals of cannabinoids, detailing processes for their preparation and their applications in therapy, cosmetics, or cannabinoid purification. Another notable patent is "Apomorphine-palmitic acid cocrystal solid particle crystalline form." This patent describes a pharmaceutical composition that includes apomorphine in a solid crystalline form, specifically as an APO·palmitic acid cocrystal solid particle crystalline form.
Career Highlights
Throughout her career, Montserrat has worked with several companies, including Enantia, S.L. and Leukos Biotech, S.L. Her innovative research has positioned her as a key figure in the cannabinoid industry, contributing to advancements in pharmaceutical formulations.
Collaborations
Montserrat has collaborated with notable professionals in her field, including Nicolas Tesson and Alexander Christian Comely. These collaborations have further enhanced her research and development efforts in cannabinoid applications.
Conclusion
Montserrat Trilla Castaño is a trailblazer in cannabinoid research, with a focus on innovative solid compositions and pharmaceutical formulations. Her contributions are paving the way for new therapeutic and cosmetic applications of cannabinoids.